Johnson & Johnson<br /> today announced that Robert J. Darretta, Vice Chairman of the Board of<br /> Directors and Chief Financial Officer, has elected to retire in early 2007<br /> after a distinguished 38-year career with the Company.<br />     "During Bob's tenure over the past decade as Chief Financial Officer,<br /> he has been instrumental in helping the Company deliver consistent,<br /> sustainable and superior performance," said William C. Weldon, Chairman and<br /> Chief Executive Officer of Johnson & Johnson. "He has been a visible and<br /> eloquent proponent of Johnson & Johnson's enduring strategic principles,<br /> and a strong advocate for the importance of Our Credo in underpinning our<br /> shared value system. We wish Bob, his wife Mary Ellen and their family the<br /> very best in the years ahead."<br />     Under Mr. Darretta's leadership in recruiting and developing talented<br /> individuals, the Company's finance organization developed a strong business<br /> focus, and has helped guide capital-efficient, profitable growth throughout<br /> the Johnson & Johnson operating companies.<br />     As Vice Chairman of the Board of Directors, Mr. Darretta had taken on<br /> additional responsibilities of importance to the Corporation, including<br /> leadership in developing new procurement practices, directing information<br /> management and process excellence functions and developing comprehensive<br /> shared services in the finance area. Outside of Johnson & Johnson, he has<br /> played a leadership role in Operation Smile, SAFE KIDS Worldwide and as a<br /> member of the Healthcare Leadership Council.<br />     Dominic J. Caruso, Vice President of Johnson & Johnson's Group Finance<br /> organization, has been appointed Corporate Vice President, Finance and<br /> Chief Financial Officer, effective January 1, 2007. He will report to Mr.<br /> Weldon and become a member of the Executive Committee.<br />     Mr. Caruso has led Johnson & Johnson's Group Finance organization since<br /> December 2005. Previously, he was Vice President, Group Finance for the<br /> Medical Devices and Diagnostics (MD&D) Group and a member of the MD&D Group<br /> Operating Committee.<br />     "Dominic has proven to be an effective leader in many facets of the<br /> business and has helped drive our strategic planning capabilities forward<br /> at both the MD&D and Corporate levels," Mr. Weldon said. "His varied<br /> experience has brought innumerable benefits to the corporation and we look<br /> forward to the valuable contributions he will make in this expanded role."<br />     Mr. Caruso joined Johnson & Johnson in October of 1999 through the<br /> acquisition of Centocor, where he was Vice President, Finance, and<br /> instrumental in the growth of that organization. He had been with Centocor<br /> since 1985 with responsibilities for finance, information management,<br /> investor relations, procurement and facility services. He also served as<br /> General Manager of Centocor's Diagnostic Division.<br />     In 2001, Mr. Caruso became Vice President, Finance for Ortho-McNeil<br /> Pharmaceutical and a member of its Management Board, before being named to<br /> the MD&D position in May, 2003. Prior to joining Centocor, he worked for<br /> the audit and tax services firm KPMG.<br />     Mr. Caruso holds a B.S. in Business Administration from Drexel<br /> University and is a certified public accountant.<br />     Johnson & Johnson is the world's most comprehensive and broadly based<br /> manufacturer of health care products, as well as a provider of related<br /> services, for the consumer, pharmaceutical, and medical devices and<br /> diagnostics markets. The more than 230 Johnson & Johnson operating<br /> companies employ approximately 116,200 men and women in 57 countries and<br /> sell products throughout the world.